Skip to search.
 Dow Down 0.60% Nasdaq Down 0.07%

CONMED Corporation (CNMD)

-NasdaqGS

27.23 Down 0.10(0.37%) May 25, 4:00PM EDT|After Hours: 27.23 0.00 (0.00%) May 25, 4:48PM EDT

ProfileGet Profile for:
CONMED Corporation
525 French Road
Utica, NY 13502
United States - Map
Phone: 315-797-8375
Fax: 315-797-0321
Website: http://www.conmed.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:3,400

Business Summary 

CONMED Corporation, a medical technology company, provides surgical devices and equipment for minimally invasive procedures and monitoring. The company’s products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery, and endoscopic technologies. It offers arthroscopy products, including powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants and related disposable products, and fluid management systems; powered surgical instruments used to perform orthopedic, arthroscopic, and other surgical procedures; and electrosurgery products comprising pencils, active electrodes, ground pads, generators, coagulation systems, and smoke evacuation and vessel sealing systems. The company’s patient care products comprise vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, ECG electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs; surgical suction instruments and tubing products; and IV products used in critical care areas. It also provides endosurgical products, such as clip appliers and laparoscopic instruments; and cutting trocars, suction/irrigation accessories, laparoscopic scissors, dissectors and graspers, active electrodes, insufflation needles, linear cutters, and staplers. In addition, the company offers endoscopic technology products comprising mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and polypectomy. Its products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology specialties. The company operates primarily in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on CONMED Corporation

Corporate Governance 
CONMED Corporation’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (Low Concern), Compensation (Medium Concern), Shareholder Rights (Medium Concern).
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Eugene R. Corasanti , 81
Founder and Chairman
85.00K0.00
Mr. Joseph J. Corasanti , 48
Chief Exec. Officer, Pres, Chief Operating Officer and Director
1.30M585.00K
Mr. Robert D. Shallish Jr.,
Chief Financial Officer, VP of Fin. and Assistant Sec.
583.00K74.00K
Mr. Luke A. Pomilio , 47
Principal Accounting Officer, VP, Corp. Gen. Mang. and Corp. Controller
564.00K143.00K
Mr. Daniel S. Jonas , 48
VP of Legal Affairs and Gen. Counsel
532.00K210.00K
Amounts are as of Dec 30, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders